Industries > Pharma > Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033
Back to Pharma Reports
Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033

Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033

Forecasts by Component (Software, Services, Hardware), by Technology (Machine Learning and Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing), by Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 22 June 2023
PAGES: 248
PRODUCT CODE: PHA1265
SUBMARKET: Next Generation Technologies

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1265 Categories: , Tags: , , , ,

The Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Personalized Treatments to Fuel the Market Progression
There has been a significant increase in the need for personalized treatments and is driven by various factors. Patients and their loved ones are increasingly seeking healthcare options that are specifically designed to address their specific needs. They aspire to receive treatments that offer a higher probability of success and fewer negative consequences. Personalized medicine holds the potential to enhance outcomes, minimize side effects, and enhance the overall satisfaction of patients.

Also, there has been a global increase in the occurrence of chronic conditions such as cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders. Asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are examples of respiratory illnesses that have become more common. Due to these disorders’ complex traits, diverse presentations, and need for specialised treatment approaches, dealing with them poses significant healthcare challenges.

The use of artificial intelligence in precision medicine is changing noticeably. The benefits provided by AI, including data integration and analysis, better diagnosis, and personalised treatment, have become well known in the sector. To take advantage of the advantages that AI-based solutions offer, pharmaceutical corporations, contract research organisations (CROs), and academic institutions are progressively integrating them into precision medicine research. The desire for cutting-edge technologies and solutions that can handle the changing needs and difficulties in the precision medicine environment is driven by these factors, which collectively contribute to the growth of the artificial intelligence market in this sector.

Data Security Concerns May Slow Down the Market Expansion
In the realm of precision medicine, the field of artificial intelligence (AI) faces significant hurdles regarding data security and privacy. As AI algorithms increasingly depend on extensive datasets encompassing genomic data, medical records, and patient information, the protection and confidentiality of sensitive data become paramount.

A notable challenge is the risk of data breaches and unauthorized access to personal health information. Precision medicine datasets comprise highly sensitive data, such as genetic profiles and comprehensive medical histories. Without adequate safeguards, these datasets become enticing targets for hackers or malicious individuals seeking personal gain or harm to individuals. Consequently, it becomes crucial to implement robust cybersecurity measures, encryption techniques, and access controls to prevent data breaches and uphold patient privacy.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Artificial intelligence in Precision Medicine market evolving?
• What is driving and restraining the Artificial intelligence in Precision Medicine market?
• How will each Artificial intelligence in Precision Medicine submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Artificial intelligence in Precision Medicine submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Artificial intelligence in Precision Medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Artificial intelligence in Precision Medicine projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Artificial Intelligence in Precision Medicine market?
• Where is the Artificial intelligence in Precision Medicine market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Artificial intelligence in Precision Medicine Market today, and over the next 10 years:
• Our 248-page report provides 91 tables, 127 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Artificial intelligence in Precision Medicine Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report Component

Component
• Software
• Services
• Hardware

Technology
• Machine Learning and Deep Learning
• Querying Method
• Natural Language Processing
• Context Aware Processing

Therapeutic Application
• Oncology
• Cardiology
• Neurology
• Respiratory
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Artificial intelligence in Precision Medicine Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Atomwise Inc.
• BPGbio, Inc.
• Exscientia
• Indivumed GmbH
• Insilico Medcine
• Intel Corporation
• Merative
• NVIDIA Corporation
• Tempus
• Zephyr AI

Overall world revenue for Artificial Intelligence in Precision Medicine Market, 2023 to 2033 in terms of value the market will surpass US$1,500 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Artificial intelligence in Precision Medicine Market, 2023 to 2033 report help you?
In summary, our 240+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Artificial intelligence in Precision Medicine Market, 2023 to 2033, with forecasts for component, technology, and therapeutic application each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the Artificial intelligence in Precision Medicine Market, 2023 to 2033 in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Artificial intelligence in Precision Medicine Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Artificial intelligence in Precision Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033: Forecasts by Component (Software, Services, Hardware), by Technology (Machine Learning and Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing), by Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Artificial Intelligence (AI) in Precision Medicine Market Report 2023-2033

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ
      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ
      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ